Clinical-scale generation of multi-specific anti-fungal T cells targeting Candida, Aspergillus and mucormycetes

Cytotherapy

Volumn 15, Issue 3, 2013, Pages 344-351

  Tramsen, Lars ^a   Schmidt, Stanislaw ^a   Boenig, Halvard ^a   Latgé, Jean Paul ^b   Lass Flörl, Cornelia ^c   Roeger, Frauke ^a   Seifried, Erhard ^a   Klingebiel, Thomas ^a   Lehrnbecher, Thomas ^a  

^a GOETHE UNIVERSITY   (Germany)

^b INSTITUT PASTEUR   (France)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Adoptive immunotherapy; Aspergillus; Candida; Invasive fungal disease; Mucormycete; T cell

Indexed keywords

CELL EXTRACT; GAMMA INTERFERON;

ALLOIMMUNITY; ARTICLE; ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL ISOLATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; FLOW CYTOMETRY; FUNGUS IMMUNITY; HUMAN; HUMAN CELL; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MEMORY T LYMPHOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHAGOCYTE; PHENOTYPE; PRIORITY JOURNAL; RHIZOPUS ORYZAE; TH1 CELL;

EID: 84875449971     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2012.11.014     Document Type: Article

References (22)

1. Kontoyiannis DP, Marr KA, Park BJ, Alexander BD, Anaissie EJ, Walsh TJ, et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: Overview of the Transplant- Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis. 2010;50:1091-100.
2. Neofytos D, Horn D, Anaissie E, Steinbach W, Olyaei A, Fishman J, et al. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: Analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Clin Infect Dis. 2009;48:265-73.
3. Pagano L, Caira M, Nosari A, Van Lint MT, Candoni A, Offidani M, et al. Fungal infections in recipients of hematopoietic stem cell transplants: Results of the SEIFEM B-2004 study-Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. Clin Infect Dis. 2007;45:1161-70.
4. Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, et al. Epidemiology and outcome of zygomycosis: A review of 929 reported cases. Clin Infect Dis. 2005;41:634-53.
5. Hamza NS, Lisgaris M, Yadavalli G, Nadeau L, Fox R, Fu P, et al. Kinetics of myeloid and lymphocyte recovery and infectious complications after unrelated umbilical cord blood versus HLA-matched unrelated donor allogeneic transplantation in adults. Br J Haematol. 2004;124:488-98.
6. Romani L. Immunity to fungal infections. Nat Rev Immunol. 2011;11:275-88.
7. Beck O, Koehl U, Tramsen L, Mousset S, Latge JP, Muller K, et al. Enumeration of functionally active anti-Aspergillus T-cells in human peripheral blood. J Immunol Methods. 2008;335:41-5.
8. Perruccio K, Tosti A, Burchielli E, Topini F, Ruggeri L, Carotti A, et al. Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation. Blood. 2005;106:4397-406.
9. Beck O, Topp MS, Koehl U, Roilides E, Simitsopoulou M, Hanisch M, et al. Generation of highly purified and functionally active human TH1 cells against Aspergillus fumigatus. Blood. 2006;107:2562-9.
10. Schmidt S, Tramsen L, Perkhofer S, Lass-Florl C, Röger F, Schubert R, et al. Characterization of the cellular immune responses to Rhizopus oryzae with potential impact on immunotherapeutic strategies in hematopoietic stem cell transplantation. J Infect Dis. 2012;206:135-9.
11. Tramsen L, Beck O, Schuster FR, Hunfeld KP, Latge JP, Sarfati J, et al. Generation and characterization of anti-Candida T cells as potential immunotherapy in patients with Candida infection after allogeneic hematopoietic stem-cell transplant. J Infect Dis. 2007;196:485-92.
12. Braedel S, Radsak M, Einsele H, Latge JP, Michan A, Loeffler J, et al. Aspergillus fumigatus antigens activate innate immune cells via toll-like receptors 2 and 4. Br J Haematol. 2004;125:392-9.
13. Tramsen L, Koehl U, Tonn T, Latge JP, Schuster FR, Borkhardt A, et al. Clinical-scale generation of human anti-Aspergillus T cells for adoptive immunotherapy. Bone Marrow Transplant. 2009;43:13-9.
14. Fujita Y, Rooney CM, Heslop HE. Adoptive cellular immunotherapy for viral diseases. Bone Marrow Transplant. 2008; 41:193-8.
15. Khanna N, Stuehler C, Conrad B, Lurati S, Krappmann S, Einsele H, et al. Generation of a multipathogen-specific T-cell product for adoptive immunotherapy based on activation-dependent expression of CD154. Blood. 2011;118: 1121-31.
16. Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferongamma: An overview of signals, mechanisms and functions. J Leukoc Biol. 2004;75:163-89.
17. Ferrara JL, Cooke KR, Teshima T. The pathophysiology of acute graft-versus-host disease. Int J Hematol. 2003;78:181-7.
18. Einsele H, Roosnek E, Rufer N, Sinzger C, Riegler S, Loffler J, et al. Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy. Blood. 2002;99:3916-22.
19. Koehne G, Smith KM, Ferguson TL, Williams RY, Heller G, Pamer EG, et al. Quantitation, selection, and functional characterization of Epstein-Barr virus-specific and alloreactive T cells detected by intracellular interferon-gamma production and growth of cytotoxic precursors. Blood. 2002;99: 1730-40.
20. Rauser G, Einsele H, Sinzger C, Wernet D, Kuntz G, Assenmacher M, et al. Rapid generation of combined CMVspecific CD4? and CD8? T-cell lines for adoptive transfer into recipients of allogeneic stem cell transplants. Blood. 2004;103:3565-72.
21. Melenhorst JJ, Leen AM, Bollard CM, Quigley MF, Price DA, Rooney CM, et al. Allogeneic virus-specific T cells with HLA alloreactivity do not produce GVHD in human subjects. Blood. 2010;116:4700-2.
22. Feuchtinger T, Matthes-Martin S, Richard C, Lion T, Führer M, Hamprecht K, et al. Safe adoptive transfer of virusspecific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation. Br J Haematol. 2006;134:64-76.